间充质干细胞
医学
伤口愈合
血管生成
细胞外基质
细胞疗法
干细胞
干细胞疗法
癌症研究
治疗性血管生成
新生血管
免疫学
病理
细胞生物学
生物
作者
Hossein Danesteh,Linda Mohammadzadeh Boukani,Narges Ramezani,Fatemeh Asadi,Haider Kamil Zaidan,Azita Sadeghzade,Maedeh Ehsannia,Ali Azarashk,Nasim Gholizadeh
标识
DOI:10.1016/j.advms.2023.10.006
摘要
Mesenchymal stem cells (MSCs) are being increasingly used in various therapeutic applications including skin tissue repair and wound healing. The positive effects of the MSCs therapy are largely elicited by immunomodulation, increasing angiogenesis, supporting extracellular matrix (ECM) and thus favoring skin structure. However, the therapeutic competences of MSC-based therapies are somewhat hindered by their apparent modest clinical merits, conferring the need for methods that would rise the efficacy of such therapies. A plethora of reports have shown that therapeutic properties of MSCs could be enhanced with other strategies and compounds like biomaterial and platelet-rich plasma (PRP) to target key possessions of MSCs and properties of adjacent tissues concurrently. Manipulation of cellular stress-response mechanisms to improve cell resistance to oxidative stress prior to or during MSC injection could also improve therapeutic efficacy of MSCs. In the current review, we shed light on the recent advances in MSCs combination therapy with other ingredients and procedures to sustain MSCs-mediated effects in wound healing.
科研通智能强力驱动
Strongly Powered by AbleSci AI